STAAR Surgical (NASDAQ:STAA) Major Shareholder Broadwood Partners, L.P. Buys 93,124 Shares

STAAR Surgical (NASDAQ:STAA - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 93,124 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were purchased at an average price of $17.54 per share, with a total value of $1,633,394.96. Following the transaction, the insider now owns 12,074,275 shares in the company, valued at $211,782,783.50. The trade was a 0.78 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, March 20th, Broadwood Partners, L.P. purchased 108,720 shares of STAAR Surgical stock. The shares were purchased at an average price of $17.96 per share, for a total transaction of $1,952,611.20.
• On Monday, March 3rd, Broadwood Partners, L.P. acquired 249,503 shares of STAAR Surgical stock. The stock was purchased at an average price of $16.64 per share, with a total value of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. bought 259,316 shares of STAAR Surgical stock. The shares were acquired at an average cost of $17.05 per share, with a total value of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. acquired 36,532 shares of STAAR Surgical stock. The stock was acquired at an average price of $15.49 per share, with a total value of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. bought 259,616 shares of STAAR Surgical stock. The shares were bought at an average price of $14.96 per share, for a total transaction of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. purchased 8,221 shares of STAAR Surgical stock. The stock was bought at an average price of $21.50 per share, with a total value of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. acquired 21,155 shares of STAAR Surgical stock. The shares were bought at an average cost of $21.46 per share, for a total transaction of $453,986.30.

STAAR Surgical Stock Performance

STAA stock traded up $0.05 during trading on Monday, hitting $17.77. The stock had a trading volume of 880,160 shares, compared to its average volume of 765,994. The stock has a market cap of $876.51 million, a price-to-earnings ratio of -43.34 and a beta of 0.66. The company's 50 day moving average price is $19.77 and its two-hundred day moving average price is $25.52. STAAR Surgical has a 1-year low of $13.50 and a 1-year high of $52.68.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a research report on Thursday, February 27th. Jefferies Financial Group cut STAAR Surgical from a "buy" rating to a "hold" rating in a report on Wednesday, February 12th. StockNews.com lowered STAAR Surgical from a "hold" rating to a "sell" rating in a report on Thursday, February 13th. William Blair downgraded STAAR Surgical from an "outperform" rating to a "market perform" rating in a research note on Wednesday, February 12th. Finally, Stifel Nicolaus lowered their price objective on shares of STAAR Surgical from $38.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $25.29.

Hedge Funds Weigh In On STAAR Surgical

Several institutional investors and hedge funds have recently modified their holdings of the company. Quarry LP purchased a new stake in STAAR Surgical in the 3rd quarter worth approximately $50,000. Quest Partners LLC purchased a new stake in shares of STAAR Surgical in the third quarter valued at $128,000. KLP Kapitalforvaltning AS acquired a new position in STAAR Surgical in the fourth quarter valued at $180,000. Larson Financial Group LLC lifted its position in STAAR Surgical by 78.3% during the third quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier's stock worth $181,000 after buying an additional 2,135 shares during the period. Finally, Bridgefront Capital LLC boosted its stake in STAAR Surgical by 27.2% in the 4th quarter. Bridgefront Capital LLC now owns 10,792 shares of the medical instruments supplier's stock worth $262,000 after buying an additional 2,306 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company's stock.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.